The Canada Life Assurance Company

Meetings over time

• May 20252 meetingsGreg Orencsak, Eric Costen, Jocelyne Voisin
  May 2025: 2 meetings, with Greg Orencsak, Eric Costen, Jocelyne Voisin
• Jun 20252 meetingsMichael Mosier, Maude Lavoie
  Jun 2025: 2 meetings, with Michael Mosier, Maude Lavoie
• Jul 20251 meetingGreg Reade, Anne David, Manish Srivastava, Khusro Saeedi
  Jul 2025: 1 meeting, with Greg Reade, Anne David, Manish Srivastava, Khusro Saeedi
• Aug 20250 meetings
  Aug 2025: 0 meetings
• Sep 20250 meetings
  Sep 2025: 0 meetings
• Oct 202512 meetingsDavid Tousignant, Khusro Saeedi, Barbara Russell, Aaron Wudrick, Philip Jennings
  Oct 2025: 12 meetings, with David Tousignant, Khusro Saeedi, Barbara Russell, Aaron Wudrick, Philip Jennings
• Nov 20251 meetingJade Mallette
  Nov 2025: 1 meeting, with Jade Mallette
• Dec 20250 meetings
  Dec 2025: 0 meetings
• Jan 20260 meetings
  Jan 2026: 0 meetings
• Feb 20268 meetingsJulien Brazeau, Jerome Côté, Mackenzy Metcalfe, Daniel MacDonald, Margaret Sharp
  Feb 2026: 8 meetings, with Julien Brazeau, Jerome Côté, Mackenzy Metcalfe, Daniel MacDonald, Margaret Sharp
• Mar 20264 meetingsRemi Gagnon, Jerome Côté, Helene Lacasse, Rémi Gagnon, Vince Gasparro
  Mar 2026: 4 meetings, with Remi Gagnon, Jerome Côté, Helene Lacasse, Rémi Gagnon, Vince Gasparro
• Apr 20261 meetingMiled Hill, Shawn Grover
  Apr 2026: 1 meeting, with Miled Hill, Shawn Grover

Hover or focus a month to see who was met.

What they lobby about

• Financial Institutions21
• Health14
• Infrastructure14
• Taxation and Finance14
• Economic Development6
• Housing6
• Science and Technology4
• International Trade2
• Pensions1
• Privacy and Access to Information1

The registry's own subject categories, chosen by the lobbyist on each filing. Each one opens its own page.

Who they met

Finance Canada (FIN) (20) · Health Canada (HC) (13) · House of Commons (6) · Senate of Canada (2) · Privy Council Office (PCO) (2) · Prime Minister's Office (PMO) (2)

In their own words

• Seeking to raise awareness about prescription drug coverage policy considerations and concerns in context of national universal pharmacare proposals directly and as a participant in the Together for Better Health Coalition. Other related initiatives include high cost drugs for rare disease and PMPRB regulations
• Federal tax policy and regulatory matters concerning the application of GST/HST to mutual fund trailing commissions. Engagement regarding implementation timelines, administrative guidance, and related impacts on financial services firms and investors.
• Digital Services Taxes and the introduction of Internal Revenue Code (IRC) Section 899 included in a recent Bill passed through the United States House of Representatives.